Literature DB >> 28211090

Development of proteinuria and focal segmental glomerulosclerosis during direct-acting antiviral therapy for hepatitis C virus infection.

Jonathan J Hogan1, Mary Ann Lim1, Matthew B Palmer2, Roy D Bloom1, Raymond T Chung3, Meghan E Sise4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28211090     DOI： 10.1002/hep.29125

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  4 in total

Review 1.  Curative Therapies for Hepatitis C Virus Infection in Patients with Kidney Disease.

Authors:  Ian A Strohbehn; Rituvanthikaa Seethapathy; Meghan Lee; Meghan E Sise
Journal:  Kidney360       Date:  2021-05-21

2.  Recurrent membranous nephropathy and acute cellular rejection in a patient treated with direct anti-HCV therapy (ledipasvir/sofosbuvir).

Authors:  Naoka Murakami; Yanli Ding; David J Cohen; Anil K Chandraker; Helmut G Rennke
Journal:  Transpl Infect Dis       Date:  2018-07-23       Impact factor: 2.228

Review 3.  Traditional Chinese Medicine in Treating Primary Podocytosis: From Fundamental Science to Clinical Research.

Authors:  Lirong Lin; En Tian; Jiangwen Ren; Zhifeng Wu; Junhui Deng; Jurong Yang
Journal:  Front Pharmacol       Date:  2022-08-08       Impact factor: 5.988

4.  A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo.

Authors:  Isabelle Desombere; Ahmed Atef Mesalam; Richard A Urbanowicz; Freya Van Houtte; Lieven Verhoye; Zhen-Yong Keck; Ali Farhoudi; Koen Vercauteren; Karin E Weening; Thomas F Baumert; Arvind H Patel; Steven K H Foung; Jonathan Ball; Geert Leroux-Roels; Philip Meuleman
Journal:  Antiviral Res       Date:  2017-10-23       Impact factor: 10.103
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.